Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

FDA, Brain Disorder

Digest more
Top News
Overview
Reactions and opinions
 · 1d · on MSN
FDA approves drug Trump touted for autism to treat other neurological disorder
The Food and Drug Administration approved leucovorin to treat a neurological disorder with some symptoms similar to autism.

Continue reading

 · 23h
FDA Approves Drug for Rare Brain Disorder, Not Autism
 · 1d · on MSN
FDA scales back vision for drug it touted as possible treatment for autism
 · 1d
FDA Finds Little Evidence That a Drug Touted by Trump Can Help People With Autism
The Food and Drug Administration on Tuesday approved a generic medication for a rare brain disorder, while walking back suggestions by President Donald Trump and other administration officials that th...

Continue reading

 · 1d
FDA contradicts Trump admin, declines to approve generic drug for autism
 · 1d
Bait and Switch? RFK Jr.’s FDA Pivots on ‘Promising’ Autism Treatment Leucovorin
 · 1d
FDA OKs drug for rare brain disorder
"There is no evidence to say that leucovorin will help most people with autism, and there's certainly no evidence to say it's safe," said Dr. Alycia Halladay of the Autism Science Foundation, in an in...

Continue reading

 · 1d
FDA reverses stance on autism drug
 · 1d
FDA Pushes Back on RFK Jr.’s Claims About Autism Drug — Report
7d

Facing A Global Challenge of Neurological Diseases

Neurological disorders affect over a third of the global population, presenting immense challenges for patients worldwide. Merz Therapeutics, a leading player in specialty neurology, aims to deliver better outcomes for more patients.
1d

With $100M, Vima pursues an oral drug for movement disorders

Incubated by Atlas Venture, the biotech startup is advancing a daily pill it sees potentially helping people with dystonia or Parkinson's disease regain control of movement.
Healthline
1y

What Are the Most Common Pediatric Neurological Disorders?

Neurological disorders affect the function of the nervous system. Common pediatric neurological disorders include ADHD, autism spectrum disorder, epilepsy, and cerebral palsy. Neurological disorders are conditions that affect the nervous system. Recent ...
TheHealthSite
13d

Rare Neurological Disorders: Subtle Early Brain Symptoms You Should Never Ignore

Unusual headaches, vision changes, mood shifts or numbness? Know the subtle early warning signs of rare neurological disorders and when to seek medical attention.
Medical News Today
1y

What are some common neurologic conditions in children?

A neurologic disorder is any condition that affects the brain and nerves throughout the body. Common neurologic conditions in children include epilepsy, cerebral palsy, attention deficit hyperactivity disorder (ADHD), and autism. Structural, chemical, or ...
Hosted on MSN
1d

WHO warns of lack of resources to treat neurological disorders

(NewsNation) — More than 1 in 3 people are living with a neurological condition, the World Health Organization found, and countries aren’t prepared to deal with it. The WHO’s Global status report on neurology found 40% of the global population is ...
News-Medical.Net
3d

Advances in mapping neurological disease through large-scale proteomics

Early prediction and identification of neurodegenerative diseases offers the best chance for prevention and treatment. Large-scale population health research enabled by the UKB-PPP has improved dementia prediction in healthy people up to 10 years before diagnosis. 1
1d

Arvinas to Present Phase 1 Data for ARV-102, a PROTAC LRRK2 Degrader, in Oral Session at the 2026 International Conference on Alzheimer’s and Parkinson’s Diseases and ...

Company to highlight new safety, pharmacokinetic, and pharmacodynamic data from Phase 1 clinical trial of ARV-102 in participants with Parkinson’s disease – NEW HAVEN, Conn., March 11, 2026 (GLOBE NEWSWIRE) -- Arvinas,
Daijiworld
5d

Mangaluru: Rise in neurological disorders among youth a concern: Dr Asha Kishore

In India, neurological diseases such as Multiple Sclerosis are increasingly being observed even among young people. The impact of these diseases is seen across all age groups. Considering various factors including genetic causes,
1don MSN

Henry Ford, Covenant announce new joint venture for neurological care

As part of the deal, Covenant HealthCare and Henry Ford Health plan to build a joint neurosciences outpatient facility in Saginaw Township.
2d

1 In 7 Indians Affected By Mental Health Disorders And Face Treatment Gaps: Experts

One in seven Indians is affected by mental health disorders, while several states continue to face a treatment gap ranging from 70 to 90 per cent as discussed in the post-budget webinar breakout session.
  • Privacy
  • Terms